Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.
Volpe S, Piperno G, Colombo F, Biffi A, Comi S, Mastroleo F, Maria Camarda A, Casbarra A, Cattani F, Corrao G, de Marinis F, Spaggiari L, Guckenberger M, Orecchia R, Alterio D, Jereczek-Fossa BA.
Volpe S, et al. Among authors: piperno g.
Cancer Treat Rev. 2022 Nov;110:102464. doi: 10.1016/j.ctrv.2022.102464. Epub 2022 Sep 20.
Cancer Treat Rev. 2022.
PMID: 36194908
Review.